KEQU
KEQU
NASDAQ · Health Care

Kewaunee Scientific Cp

$36.68
+0.11 (+0.30%)
As of Jul 4, 10:45 PM ET ·
Financial Highlights (FY 2026)
Revenue
271.36M
Net Income
9.26M
Gross Margin
28.5%
Profit Margin
3.4%
Rev Growth
+8.7%
D/E Ratio
0.62
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.5% 28.5% 50.5% 50.5%
Operating Margin 5.9% 5.3% 10.7% 9.9%
Profit Margin 3.4% 3.2% 9.0% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 271.36M 249.61M 59.81M 50.24M
Gross Profit 77.39M 71.19M 30.19M 25.36M
Operating Income 16.09M 13.32M 6.40M 4.98M
Net Income 9.26M 7.66M 5.37M 4.75M
Gross Margin 28.5% 28.5% 50.5% 50.5%
Operating Margin 5.9% 5.3% 10.7% 9.9%
Profit Margin 3.4% 3.2% 9.0% 9.5%
Rev Growth +8.7% +8.7% +13.1% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 20.17M 20.17M 32.14M 29.26M
Total Equity 32.48M 32.48M 76.20M 84.12M
D/E Ratio 0.62 0.62 0.42 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 21.70M 18.96M 8.28M 7.47M
Free Cash Flow 3.50M 3.36M